| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,610,000 |
| Market
Cap: |
83.22(M) |
| Last
Volume: |
1,136,985 |
Avg
Vol: |
1,133,856 |
| 52
Week Range: |
$0.900001 - $2.955 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Media |
| Level
III Sector: |
Broadcasting - TV |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Co. is seeking to develop IRX-2, a cytokine-based therapy, to treat patients with cancer. Co. also is exploring opportunities to advance oncology, blood disorder, and monogenic disease therapies using gene-editing and cell therapy technology through a license with Factor Bioscience Limited and through its subsidairies, Novellus, Inc. and Novellus, Ltd.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
880,962 |
| Total Buy Value |
$0 |
$0 |
$0 |
$2,889,556 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ellin Robert S |
10% Owner |
– – • |
2019-09-30 |
4 |
B |
$3.33 |
$333 |
I/I |
100 |
194,926 |
1.42 |
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-09-26 |
4 |
B |
$2.95 |
$14,245 |
I/I |
4,831 |
194,826 |
1.5 |
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-09-25 |
4 |
B |
$2.81 |
$14,475 |
I/I |
5,150 |
189,995 |
1.5 |
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-09-24 |
4 |
B |
$2.44 |
$57,474 |
I/I |
23,550 |
184,845 |
1.5 |
- |
|
| Gurrola Sandra M |
SVP of Finance |
• – – |
2019-09-24 |
4 |
D |
$2.28 |
$1,035 |
D/D |
(454) |
9,321 |
|
- |
|
| Wolff Allen |
Interim CEO |
• – – |
2019-09-24 |
4 |
D |
$2.28 |
$1,646 |
D/D |
(722) |
57,425 |
|
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-09-13 |
4 |
B |
$2.27 |
$3,516 |
D/D |
1,551 |
153,963 |
2.37 |
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-09-12 |
4 |
B |
$2.26 |
$16,852 |
I/I |
7,451 |
161,295 |
1.5 |
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-09-11 |
4 |
B |
$2.31 |
$5,092 |
I/I |
2,200 |
153,844 |
1.5 |
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-09-11 |
4 |
B |
$2.28 |
$2,056 |
D/D |
900 |
152,412 |
2.37 |
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-09-10 |
4 |
B |
$2.56 |
$9,463 |
I/I |
3,700 |
151,644 |
1.5 |
- |
|
| Gurrola Sandra M |
VP of Finance |
• – – |
2019-08-27 |
4 |
D |
$2.77 |
$97 |
D/D |
(35) |
9,775 |
|
- |
|
| Wolff Allen |
CFO and EVP |
• – – |
2019-08-27 |
4 |
D |
$2.77 |
$391 |
D/D |
(141) |
58,147 |
|
- |
|
| Krishnan Ram |
CEO |
• • – |
2019-08-27 |
4 |
D |
$2.77 |
$668 |
D/D |
(241) |
102,375 |
|
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-08-23 |
4 |
S |
$2.75 |
$555 |
I/I |
(200) |
147,944 |
|
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-07-30 |
4 |
B |
$3.23 |
$27,910 |
I/I |
8,651 |
148,144 |
1.5 |
- |
|
| Gurrola Sandra M |
VP of Finance |
• – – |
2019-07-30 |
4 |
D |
$3.18 |
$108 |
D/D |
(34) |
9,810 |
|
- |
|
| Krishnan Ram |
CEO |
• • – |
2019-07-30 |
4 |
D |
$3.18 |
$763 |
D/D |
(240) |
102,616 |
|
- |
|
| Wolff Allen |
CFO and EVP |
• – – |
2019-07-30 |
4 |
D |
$3.18 |
$448 |
D/D |
(141) |
58,288 |
|
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-07-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
139,493 |
|
- |
|
| Ellin Robert S |
10% Owner |
– – • |
2019-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
151,512 |
|
- |
|
| Gurrola Sandra M |
VP of Finance |
• – – |
2019-06-21 |
4 |
D |
$3.47 |
$118 |
D/D |
(34) |
9,844 |
|
- |
|
| Wolff Allen |
CFO and EVP |
• – – |
2019-06-21 |
4 |
D |
$3.47 |
$489 |
D/D |
(141) |
58,429 |
|
- |
|
| Krishnan Ram |
CEO |
• • – |
2019-06-21 |
4 |
D |
$3.47 |
$815 |
D/D |
(235) |
102,856 |
|
- |
|
| Wolff Allen |
CFO and EVP |
• – – |
2019-05-21 |
4 |
D |
$2.89 |
$494 |
D/D |
(171) |
58,570 |
|
- |
|
232 Records found
|
|
Page 5 of 10 |
|
|
0.03 (1.48%) 
